Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
386M
-
Number of holders
-
83
-
Total 13F shares, excl. options
-
38.1M
-
Shares change
-
+1.03M
-
Total reported value, excl. options
-
$227M
-
Value change
-
+$6.13M
-
Put/Call ratio
-
0.95
-
Number of buys
-
41
-
Number of sells
-
-40
-
Price
-
$5.96
Significant Holders of STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share (LAB) as of Q2 2018
100 filings reported holding LAB - STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share as of Q2 2018.
STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share (LAB) has 83 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 38.1M shares
of 386M outstanding shares and own 9.85% of the company stock.
Largest 10 shareholders include LEVIN CAPITAL STRATEGIES, L.P. (10.2M shares), PRIMECAP MANAGEMENT CO/CA/ (5.79M shares), Neuberger Berman Group LLC (4.51M shares), Russell Investments Group, Ltd. (4.39M shares), BlackRock Inc. (2M shares), ORBIMED ADVISORS LLC (1.58M shares), VANGUARD GROUP INC (1.29M shares), RENAISSANCE TECHNOLOGIES LLC (1.07M shares), STATE STREET CORP (593K shares), and Healthcare Value Capital, LLC (450K shares).
This table shows the top 83 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.